# SUCCINYLCHOLINE CHLORIDE
> **ANDA214491** · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2020-12-21
## Drug
- **FDA Application Number:** ANDA214491
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUCCINYLCHOLINE CHLORIDE
- **Generic name:** SUCCINYLCHOLINE CHLORIDE
- **Active ingredients:** SUCCINYLCHOLINE CHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** DEVA HOLDING AS
- **Manufacturer:** Devatis, Inc.
- **First approval:** 2020-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214491)
---
*MORVS · CC0 1.0*